Perrigo Quarterly Balance Sheet
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Perrigo financial position
As of Jun 27, 2026, Perrigo reported total assets of $7.61 billion, down 24.6% from a year earlier against total liabilities of $5.09 billion. Shareholders' equity stood at $2.52 billion, or 33.1% of assets. The company held $399.7 million in cash and equivalents against $3.29 billion of debt, a net debt position of $2.90 billion.
The current ratio (current assets divided by current liabilities) was 2.32, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.31.
Summary generated from market data by MetaCap's automated system. Methodology
Perrigo balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-27 | Q1 20262026-03-28 | Q4 20252025-12-31 | Q3 20252025-09-27 | Q2 20252025-06-28 | Q1 20252025-03-29 | Q4 20242024-12-31 | Q3 20242024-09-28 | Q2 20242024-06-29 | Q1 20242024-03-30 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 399.70M | 357.20M | 531.60M | 432.10M | 454.20M | 409.90M | 558.80M | 1.46B | 542.80M | 658.50M | 751.30M | 598.30M |
| Receivables | 709.90M | 697.10M | 612.80M | 644.40M | 678.20M | 716.80M | 642.30M | 785.90M | 726.00M | 780.00M | 739.60M | 737.80M |
| Inventory | 1.06B | 1.12B | 1.15B | 1.23B | 1.22B | 1.16B | 1.08B | 1.13B | 1.12B | 1.12B | 1.14B | 1.15B |
| Total Current Assets | 2.45B | 2.71B | 2.80B | 2.88B | 2.62B | 2.53B | 2.48B | 3.71B | 2.96B | 2.81B | 2.83B | 2.77B |
| Property, Plant & Equipment | 849.00M | 877.70M | 898.70M | 902.80M | 913.90M | 913.20M | 917.80M | 909.10M | 909.90M | 911.40M | 916.40M | 902.90M |
| Goodwill | 1.69B | 1.70B | 2.05B | 3.36B | 3.48B | 3.38B | 3.32B | 3.42B | 3.37B | 3.49B | 3.53B | 3.55B |
| Intangible Assets | 4.55B | 4.58B | 4.76B | 4.74B | 4.94B | 4.66B | 4.50B | 4.81B | 4.71B | 4.92B | 5.00B | 4.85B |
| Total Assets | 7.61B | 7.98B | 8.54B | 10.08B | 10.09B | 9.76B | 9.65B | 11.20B | 10.40B | 10.64B | 10.81B | 10.76B |
| Accounts Payable | 400.40M | 434.80M | 474.50M | 469.70M | 489.00M | 502.30M | 495.20M | 458.50M | 471.50M | 453.70M | 477.70M | 433.10M |
| Short-Term Debt | 11.40M | 11.40M | 36.60M | 36.60M | 36.40M | 36.20M | 36.40M | 440.70M | 440.80M | 440.60M | 440.60M | 38.10M |
| Total Current Liabilities | 1.05B | 997.60M | 1.01B | 1.15B | 1.13B | 1.07B | 1.04B | 1.45B | 1.49B | 1.55B | 1.59B | 1.01B |
| Long-Term Debt | 3.28B | 3.62B | 3.60B | 3.61B | 3.62B | 3.59B | 3.58B | 4.31B | 3.62B | 3.62B | 3.63B | 4.05B |
| Total Liabilities | 5.09B | 5.48B | 5.60B | 5.64B | 5.62B | 5.40B | 5.33B | 6.64B | 5.85B | 5.95B | 6.04B | 6.02B |
| Shareholders' Equity | 2.52B | 2.50B | 2.94B | 4.45B | 4.47B | 4.36B | 4.32B | 4.57B | 4.55B | 4.69B | 4.77B | 4.74B |
| Retained Earnings | -4.00B | -4.08B | -3.68B | -2.26B | -2.27B | -2.26B | -2.25B | -2.21B | -2.19B | -2.08B | -2.08B | -2.05B |
| Total Debt | 3.29B | 3.63B | 3.64B | 3.64B | 3.65B | 3.63B | 3.62B | 4.75B | 4.06B | 4.07B | 4.07B | 4.09B |
| Net Cash (Debt) | -2.90B | -3.28B | -3.11B | -3.21B | -3.20B | -3.22B | -3.06B | -3.29B | -3.51B | -3.41B | -3.32B | -3.49B |
| Shares Outstanding | 138.70M | 138.10M | 137.60M | 137.60M | 137.60M | 137.20M | 136.50M | 136.50M | 136.40M | 136.30M | 135.50M | — |
This table shows 12 quarterly periods of Perrigo's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PRGO's reporting calendar. What is a balance sheet?